Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to ...
A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.